Reishi, Lingzhi · 2022 · Journal Article
Low relevanceSpiroganodermaines A-G from Ganoderma species and their activities against insulin resistance and renal fibrosis.
Ganoderma lucidum
Key points
- Ganoderma mushrooms are a renowned Chinese medicine and functional food used worldwide
- Seven undescribed spiro Ganoderma meroterpenoids spiroganodermaines A-G were isolated from Ganoderma species
- Their structures were characterized by using spectroscopic, computational and X-ray diffraction methods
- Biological studies showed that (+)-spiroganodermaine G significantly activates glucose uptake and IRS1 phosphorylation in insulin resistance C2C12 cells
- Furthermore, (-)-spiroganodermaine G inhibits the expressions of fibronectin and α-SMA in TGF-β1 induced NRK-52E cells
- These findings demonstrate the potential of Ganoderma meroterpenoids as medicines and dietary supplements
Metadata-grounded summary
Citation abstract
Ganoderma mushrooms are a renowned Chinese medicine and functional food used worldwide. Seven undescribed spiro Ganoderma meroterpenoids spiroganodermaines A-G were isolated from Ganoderma species. Their structures were characterized by using spectroscopic, computational and X-ray diffraction methods. Biological studies showed that (+)-spiroganodermaine G significantly activates glucose uptake and IRS1 phosphorylation in insulin resistance C2C12 cells. Furthermore, (-)-spiroganodermaine G inhibits the expressions of fibronectin and α-SMA in TGF-β1 induced NRK-52E cells. These findings demonstrate the potential of Ganoderma meroterpenoids as medicines and dietary supplements.
Citation
Zhang JJ, Wang DW, Peng YL, Cai D, Cheng YX (2022). Spiroganodermaines A-G from Ganoderma species and their activities against insulin resistance and renal fibrosis. Phytochemistry https://doi.org/10.1016/j.phytochem.2022.113324 PMID: 35931232
Open citation